Cambridge University Hospitals NHS Foundation Trust
Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, maternity and tertiary NHS services to approximately 5 million people across the East of England while serving as a major translational clinical research and AI-data hub.
- Company typePrivate
- Founded1992
- HeadquartersCambridge, United Kingdom
- Headcount5,001–10,000
- GTM typeB2C
- OfferingServices
What Cambridge University Hospitals NHS Foundation Trust does
Cambridge University Hospitals NHS Foundation Trust (CUH) is a UK NHS Foundation Trust — a public benefit corporation — that operates Addenbrooke's Hospital and The Rosie Hospital from a single site on Hills Road, Cambridge, as the regional specialist centre for the East of England. It delivers acute, specialist and tertiary services — emergency care, cancer, cardiology, children's services, maternity, robotic surgery and clinical research — to a population of approximately 5 million, with around 1 million patient contacts per year and 10,000+ employees.
Its technology stack is anchored by an Epic electronic health record that powers the MyChart patient portal and underpins an Epic-based Digital Research Environment used for AI/ML research on de-identified data. The Trust additionally hosts the East of England Secure Data Environment (EoE SDE), runs the OPTICA patient-flow application on the NHS Federated Data Platform, operates a CAR-T cell manufacturing laboratory built with the University of Cambridge, and runs the Cambridge Digital Health and Surgical Training Centre with hands-on training on da Vinci, Versius and Hugo RAS robotic surgery systems plus extended reality and AI-based immersive training.
CUH's revenue model is dominated by statutory NHS funding for public healthcare delivery, supplemented by competitive research grants (e.g., a £1.4m NIHR grant for the CAR-T lab), a five-year Strategic Research Agreement with Arcturis (formerly Sensyne Health) licensing access to 3 million de-identified patient records in exchange for a 2.6% equity stake, up to £350,000/year IT investment and royalties, philanthropic donations via Addenbrooke's Charitable Trust (including a £10m gift), and income from private and overseas patients through the Paying Patients Office. Services are free at the point of use for NHS patients; pricing for non-NHS patients is not publicly listed.
Cambridge University Hospitals NHS Foundation Trust firmographics
Firmographics- Name
- Cambridge University Hospitals NHS Foundation Trust
- Legal name
- Cambridge University Hospitals NHS Foundation Trust
- Website
- https://cuh.nhs.uk
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, maternity and tertiary NHS services to approximately 5 million people across the East of England while serving as a major translational clinical research and AI-data hub.
- Ownership category
- akta.pro rank
Where Cambridge University Hospitals NHS Foundation Trust is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Offices5 records
Markets served
Cambridge University Hospitals NHS Foundation Trust business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Others
Revenue model
- Statutory NHS funding: Primary funding as an NHS Foundation Trust delivering public healthcare services free at the point of use across Cambridgeshire, Peterborough, and the East of England region.
- Strategic Research Agreement with Arcturis (formerly Sensyne Health): Five-year SRA signed December 2021 providing non-exclusive access to three million longitudinal de-identified patient records. CUH received 4,285,714 ordinary shares (2.6% of Sensyne) and an investment of up to £350,000 per year, plus royalties on revenues generated by Sensyne from research under the SRA.
- Charitable donations via Addenbrooke's Charitable Trust (ACT): Donations and philanthropy supporting the Trust's work, including a £10m donation from a New Zealand businessman to establish the Charlotte Lockhart Precision Breast Cancer Institute.
- Research grants (NIHR): Competitive grant funding such as the £1.4 million grant from the NIHR supporting the new CAR-T cell manufacturing laboratory at Addenbrooke's Hospital.
- Paying Patients Office (private/overseas patient income): Income from overseas patients and private/overseas patient services managed through the Paying Patients Office.
Go-to-market motion3 records
Distribution channels6 records
Marketing channels7 records
Cambridge University Hospitals NHS Foundation Trust product offering
Product offeringCore offering
Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, and tertiary healthcare services to a population of approximately five million across the East of England. The Trust provides a full clinical service portfolio including emergency, cancer, cardiology, children's, maternity, imaging, and outpatient services, supported by digital tools (MyChart, CUH Directions), research platforms (East of England Secure Data Environment), a CAR-T cell manufacturing laboratory, and the Cambridge Digital Health and Surgical Training Centre.
Product overview
Cambridge University Hospitals NHS Foundation Trust (CUH) is a UK NHS acute hospital trust operating two core hospital sites — Addenbrooke's Hospital and The Rosie Hospital — and a portfolio of digital, research and training products and services. Its core clinical service portfolio is delivered through these hospitals and is supported by digital products such as the MyChart patient portal and the CUH Directions mobile app (both integrating with the underlying Epic electronic health record), data and research platforms including the East of England Secure Data Environment and the Strategic Research Agreement with Arcturis (formerly Sensyne Health), and emerging capital projects such as the CAR-T cell manufacturing laboratory and the planned Cambridge Cancer Research Hospital (target 2029). The Trust also operates the Cambridge Digital Health and Surgical Training Centre, which hosts the START robotic-surgery training programme with the Shelford Group and Newcastle Surgical Training Centre, and uses the NHS Federated Data Platform (via the OPTICA product) for real-time patient discharge tracking and flow optimisation.
Differentiator
Problem solved
Functional benefit
Brands
- MyChart: Patient portal app launched by CUH providing secure online access to health records, appointments, medication, messages and test results.
- CUH Directions
- Cambridge Digital Health and Surgical Training Centre
- Addenbrooke's Charitable Trust (ACT)
- East of England Secure Data Environment (EoE SDE)
Products and services
- Addenbrooke's Hospital Main acute hospital of Cambridge University Hospitals NHS Foundation Trust, providing emergency, surgical, and medical care to NHS patients across Cambridgeshire, Peterborough, and the East of England region.
- The Rosie Hospital CUH's dedicated women's and maternity hospital, co-located with Addenbrooke's, providing maternity services, the Rosie birth centre, neonatal care, and women's health research.
- MyChart Patient Portal Patient-facing mobile app providing secure online access to hospital information including visits, medications, messages, test results, and appointment management. Integrates with the underlying Epic electronic health record.
- CUH Directions Mobile App Mobile wayfinding application that helps patients and visitors navigate around the Addenbrooke's and Rosie hospital sites.
- East of England Secure Data Environment (EoE SDE) Nationally funded programme hosted by CUH that supports secure access to anonymised data for approved research projects and public interest initiatives, underpinned by a research database with existing CAG and NHS Research Ethics Committee approval.
- Cambridge Digital Health and Surgical Training Centre 12,000 square foot training facility providing hands-on training on Intuitive da Vinci, CMR Surgical Versius, and Medtronic Hugo RAS robotic surgery systems through the START programme, with a Digital Health Training Centre offering extended reality and AI-based immersive training.
- CAR-T Cell Manufacturing Laboratory State-of-the-art laboratory at Addenbrooke's Hospital, built by the University of Cambridge and operated by CUH, to manufacture CAR-T cells for clinical trials and personalised immunotherapy treatments for cancers and autoimmune diseases.
- CUH Clinical Services A-Z Full portfolio of clinical services including Emergency Department, Cancer Services, Cardiology, Children's Services, Ear Nose and Throat, Endoscopy, Imaging, Community Diagnostic Centres and Outpatients.
Quantifiable outcome
- Robot-assisted Whipple's procedures (East of England first) - patients reported minimal pain and speedy recovery compared to traditional surgery which typically requires several months of recovery
- +3 more outcomes
Companies that use Cambridge University Hospitals NHS Foundation Trust
Customer profileSegments5 records
Ideal customer profiles5 records
Cambridge University Hospitals NHS Foundation Trust technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
AI capability10 records
Feature9 records
Cambridge University Hospitals NHS Foundation Trust partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered minor, core and flagship.
- Cyclana BiominorNHS Foundation Trust partner hosting the PEMP 500-patient clinical observational study in endometriosis at the Rosie Hospital in Cambridge (with Peterborough City Hospital as the lead site), funded by Cyclana Bio's £5M pre-seed funding round.
- Shelford GroupcoreCo-delivers the Shelford Surgical Training in Advanced Robotic Technology (START) programme in partnership with the Newcastle Surgical Training Centre from the Cambridge Digital Health and Surgical Training Centre. Provides hands-on training on Intuitive da Vinci, CMR Surgical Versius, and Medtronic Hugo RAS robotic surgery systems.
- Newcastle Surgical Training CentrecoreCo-delivers the Shelford Surgical Training in Advanced Robotic Technology (START) programme alongside the Shelford Group from CUH's 12,000 square foot Cambridge Digital Health and Surgical Training Centre.
- Royal College of Surgeons of EnglandcoreProvides support to the Cambridge Digital Health and Surgical Training Centre and the START programme to advance robot-assisted surgery training across the UK.
- Intuitive Surgical (da Vinci)coreProvider of the da Vinci robotic surgery platform used in hands-on training at the Cambridge Digital Health and Surgical Training Centre's START programme.
- CMR Surgical (Versius)coreProvider of the Versius robotic surgery platform used in hands-on training at the Cambridge Digital Health and Surgical Training Centre's START programme.
- Medtronic (Hugo RAS)coreProvider of the Hugo RAS robotic surgery platform used in hands-on training at the Cambridge Digital Health and Surgical Training Centre's START programme.
- University of CambridgeflagshipBuilt the new state-of-the-art CAR-T cell manufacturing laboratory at Addenbrooke's Hospital, with the laboratory operated by Cambridge University Hospitals NHS Foundation Trust. The facility is supported by a £1.4 million grant from the NIHR and aims to manufacture CAR-T cells for clinical trials and personalised immunotherapy treatment for cancers and autoimmune diseases.
- NHS England (NHS Federated Data Platform)coreRequired by the NHS England Medium Term Planning Framework (Delivering Change Together 2026/27 to 2028/29), CUH uses an instance of the NHS Federated Data Platform including OPTICA, an NECS-built cloud application for tracking admitted patients and discharge tasks. Contract for the FDP supplier was awarded by NHS England in November 2023.
- NECS (North of England Commissioning Support)coreBuilder of OPTICA (Optimised Patient Tracking & Intelligent Choices Application) in collaboration with NHS trusts and local authorities, providing real-time tracking of admitted patients and discharge tasks within the NHS Federated Data Platform.
- Epic (Electronic Health Record)flagshipUnderpins the CUH Digital Research Environment, supporting safe, efficient data processing and rapid transfer of de-identified data for the Sensyne/Arcturis SRA. The Epic EHR also stores patient records, which are subject to long-term retention under the Trust's records management policy.
- Arcturis (formerly Sensyne Health)flagshipFive-year Strategic Research Agreement (SRA) signed in December 2021 granting non-exclusive access to three million longitudinal de-identified patient records for clinical AI research. CUH received 4,285,714 ordinary shares (2.6% of Sensyne) and an investment of up to £350,000 per year over the five-year term, plus royalties on Sensyne's revenues from research under the SRA. Research focus areas include cancer, cardiovascular disease, and rare diseases, including clinical decision tools, AI for retrospective clinical data analysis, and drug discovery.
Scale indicators11 records
Recent moves8 records
Expansion highlights8 records
Cambridge University Hospitals NHS Foundation Trust competitors and assessment
Company assessmentDirect peers
- Oxford University Hospitals NHS Foundation Trust: University teaching hospital trust co-located with a world-leading research university; runs a similar mix of acute, specialist, and research services, comparable to CUH in scale, digital maturity, and academic-commercial partnerships.
- Imperial College Healthcare NHS Trust: Large London university teaching trust with a comparable portfolio of acute and specialist services, biomedical campus co-location, and translational research capability directly comparable to CUH's Addenbrooke's-led model.
- University College London Hospitals NHS Foundation Trust (UCLH): Major central-London teaching trust combining acute, specialist, and biomedical research on a single campus; operates similar Epic-based digital infrastructure and runs a research/data partnership model analogous to CUH.
- Guy's and St Thomas' NHS Foundation Trust: Large multi-site teaching trust with extensive research and commercial partnership activity (incl. King's Health Partners); comparable to CUH in research intensity, digital strategy, and teaching hospital remit.
- The Newcastle upon Tyne Hospitals NHS Foundation Trust: Northern England teaching trust and named co-delivery partner with CUH in the Shelford START robotic-surgery training programme; directly comparable in scale, research activity, and surgical training capability.
- King's College Hospital NHS Foundation Trust: Major London teaching trust providing tertiary and specialist services (including a large liver/haematology/oncology portfolio); overlaps with CUH in specialist caseload mix and academic-clinical partnership model.
- Manchester University NHS Foundation Trust: One of the largest UK acute/teaching trusts formed by merger; comparable to CUH in scale, multi-site operating model, and translational research activity.
- Barts Health NHS Trust: Large London teaching trust running multiple acute hospitals with significant research output; comparable to CUH in size, digital ambition, and complex public-sector operating environment.
Regional players
- Royal Papworth Hospital NHS Foundation Trust: Specialist cardiothoracic trust also located on the Cambridge Biomedical Campus, providing tertiary services to the East of England; comparable as a co-located specialist partner rather than a direct acute competitor.
- Great Ormond Street Hospital for Children NHS Foundation Trust: UK specialist children's hospital trust with very high research intensity and commercial trial activity; comparable to CUH in translational research model but with a narrower, paediatric specialist scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Cambridge University Hospitals NHS Foundation Trust social profiles
Digital presenceCambridge University Hospitals NHS Foundation Trust compliance and trust
Trust signalCompliance7 records
Cambridge University Hospitals NHS Foundation Trust financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cambridge University Hospitals NHS Foundation Trust leadership team
Management profileNumber of profiles
Profiles2 records
Cambridge University Hospitals NHS Foundation Trust subsidiaries and ownership
Company hierarchySubsidiaries2 records
Cambridge University Hospitals NHS Foundation Trust funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cambridge University Hospitals NHS Foundation Trust M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cambridge University Hospitals NHS Foundation Trust
What does Cambridge University Hospitals NHS Foundation Trust do?
Cambridge University Hospitals NHS Foundation Trust operates Addenbrooke's Hospital and The Rosie Hospital in Cambridge, delivering acute, specialist, and tertiary healthcare services to a population of approximately five million across the East of England. The Trust provides a full clinical service portfolio including emergency, cancer, cardiology, children's, maternity, imaging, and outpatient services, supported by digital tools (MyChart, CUH Directions), research platforms (East of England Secure Data Environment), a CAR-T cell manufacturing laboratory, and the Cambridge Digital Health and Surgical Training Centre.
Is Cambridge University Hospitals NHS Foundation Trust a public or private company?
Cambridge University Hospitals NHS Foundation Trust is a private company. It is classified as state government owned and is currently operating.
When was Cambridge University Hospitals NHS Foundation Trust founded?
Cambridge University Hospitals NHS Foundation Trust was founded in 1992. It employs 5,001 to 10,000 people.
Where is Cambridge University Hospitals NHS Foundation Trust based?
Cambridge University Hospitals NHS Foundation Trust is headquartered in Cambridge, United Kingdom, in the Europe region.
How does Cambridge University Hospitals NHS Foundation Trust make money?
Five revenue lines are on record. Statutory NHS funding is the primary driver. The others are strategic Research Agreement with Arcturis (formerly Sensyne Health), charitable donations via Addenbrooke's Charitable Trust (ACT), research grants (NIHR) and paying Patients Office (private/overseas patient income).
Who are Cambridge University Hospitals NHS Foundation Trust's main competitors?
Direct peers on record are Oxford University Hospitals NHS Foundation Trust, Imperial College Healthcare NHS Trust, University College London Hospitals NHS Foundation Trust (UCLH), Guy's and St Thomas' NHS Foundation Trust, The Newcastle upon Tyne Hospitals NHS Foundation Trust, King's College Hospital NHS Foundation Trust, Manchester University NHS Foundation Trust and Barts Health NHS Trust. Regional players are Royal Papworth Hospital NHS Foundation Trust and Great Ormond Street Hospital for Children NHS Foundation Trust.
Does Cambridge University Hospitals NHS Foundation Trust have an API?
No public API is recorded for Cambridge University Hospitals NHS Foundation Trust.